Ledger.Open graph →
SEC Form D · filed April 26, 2024

AsclepiX Therapeutics, Inc

Offering
$12.5M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Bethesda, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Robert Dempsey · Newport Beach, CAExecSapna Srivastava · CAMBRIDGE, MADirectorAmir Shojaei · Wapole, MAExecJordan Green · Clarksdale, MSDirectorSteven Altschuler · New York, NYDirectorBen Askew · SEATTLE, WADirectorJosh Barer · Bethesda, MDDirectorChris Garabedian · Delanson, NYDirectorAleksander Popel · Bethesda, MDExecAmir Shojaei · Wapole, MAExecNiranjan Pandey · Bethesda, MDExecJill Tierney · Bethesda, MDExecRobert Dempsey · Newport Beach, CAExecSteven Altschuler · New York, NYDirectorBen Askew · SEATTLE, WADirectorJosh Barer · Bethesda, MDDirectorChris Garabedian · Delanson, NYDirectorAleksander Popel · Bethesda, MDExecSapna Srivastava · CAMBRIDGE, MADirectorAmir Shojaei · Bethesda, MDExecNiranjan Pandey · Bethesda, MDExecJill Tierney · Bethesda, MDExecJordan Green · Clarksdale, MSDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗